Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

COVID-origins report sparks debate over major genome hub GISAID

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Nature 616, 13-14 (2023)

doi: https://doi.org/10.1038/d41586-023-00901-9

Updates & Corrections

  • Update 31 March 2023: GISAID has now removed the additional restrictions that it had introduced for access to the China CDC data; the story has been changed to reflect that.

  • Correction 31 March 2023: An earlier version of this story said that GISAID had clarified its rules for access to the China CDC data after the Zenodo report was posted; in fact it added more restrictions.

References

  1. Crits-Christoph, A. et al. Report at Zenodo https://doi.org/10.5281/zenodo.7754299 (2023).

  2. Gao, G. et al. Preprint at Research Square https://doi.org/10.21203/rs.3.rs-1370392/v1 (2022).

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links